MabGenesis Inc. (TYO:653A)
640.00
-26.00 (-3.90%)
Nov 18, 2026, 10:50 AM JST
MabGenesis Market Cap
MabGenesis has a market cap or net worth of 5.16 billion as of November 17, 2026. It is the 33,468th most valuable company in the world and the 3,055th biggest in Japan.
Market Cap
5.16B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#3,055 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 2, 2026, MabGenesis's market cap has decreased from 5.61B to 5.16B, a decrease of -8.05%. That is a compound annual growth rate of -85.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 5.16B | -3.90% |
| Nov 17, 2026 | 5.36B | 5.88% |
| Nov 16, 2026 | 5.07B | 3.28% |
| Nov 13, 2026 | 4.91B | 10.53% |
| Nov 12, 2026 | 4.44B | -6.45% |
| Nov 11, 2026 | 4.74B | 0.17% |
| Nov 10, 2026 | 4.74B | -17.42% |
| Nov 9, 2026 | 5.73B | -4.94% |
| Nov 6, 2026 | 6.03B | 2.60% |
| Nov 5, 2026 | 5.88B | -4.70% |
| Nov 4, 2026 | 6.17B | 10.06% |
| Nov 2, 2026 | 5.61B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TMS Co., Ltd. | 6.12B |
| Nano Holdings | 6.10B |
| Chiome Bioscience | 6.08B |
| CellSource | 5.60B |
| Soiken Holdings | 5.52B |
| BrightPath Biotherapeutics | 5.28B |
| Cyfuse Biomedical K.K. | 5.12B |
| MEDINET | 4.84B |